TapImmune Inc Share Price Nasdaq
Equities
US8760334081
Biotechnology & Medical Research
Sales 2022 | 9.01M 718M | Sales 2023 | 3.31M 264M | Capitalization | 48.89M 3.89B |
---|---|---|---|---|---|
Net income 2022 | -29M -2.31B | Net income 2023 | -8M -637M | EV / Sales 2022 | 2.06 x |
Net cash position 2022 | 4.17M 332M | Net cash position 2023 | 15.11M 1.2B | EV / Sales 2023 | 10.2 x |
P/E ratio 2022 |
-0.74
x | P/E ratio 2023 |
-5.88
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.83% |
Latest transcript on TapImmune Inc
Managers | Title | Age | Since |
---|---|---|---|
Juan F. Vera
CEO | Chief Executive Officer | 44 | 16/10/18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/10/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 16/10/18 | |
Steven Elms
BRD | Director/Board Member | 60 | 05/08/19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 07/12/21 |
1st Jan change | Capi. | |
---|---|---|
+1.33% | 42.75B | |
+47.70% | 41.61B | |
+11.49% | 41.34B | |
-8.83% | 26.59B | |
+6.36% | 25.49B | |
-23.57% | 18.12B | |
+29.87% | 12.24B | |
-2.50% | 11.76B | |
+7.84% | 11B |